View Author
mesenchymal transplantation proliferation effect expression study tissue culture patient marrow heart donor differentiation transplant capacity factor blood therapy organ adipose tissue disease organ transplantation t cells bone marrow control adipose analysis allogeneic response kidney 7 days lymphocyte flammatory graft medium result level stromal t-cell model marker lymphocytes rapamycin liver nk cells condition figure hoogduijn tacrolimu autologou rejection treatment msc cultures number system serum function population signi immunomodulatory msc-rd activation immunosuppression survival pbmc proliferation nicotinic presence cytokine sample receptor liver transplantation production lymphocyte proliferation adult ratio concentration immunol netherland 30 min infusion
10 Most Recent Publications
|
Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy
(Article)
Reinders, M.E. Roemeling-Van Rhijn, M. Hoogduijn, M.J. Fibbe, W.E. Fijter, J.W. de Kooten, C. van Rabelink, T.J. Roelofs, H.M.J. Khairoun, M. Lievers, E. Vries, D.K. de Schaapherder, A.F.M. Wong, S.W.S. Zwaginga, J.J. Duijs, J.M. Zonneveld, A.J. van |
2013-06-01
|
|
Effect of arthritic synovial fluids on the expression of immunomodulatory factors by mesenchymal stem cells: An explorative in vitro study
(Article)
Leijs, M.J.C. Buul, G.M. van Lubberts, E.W. Bos, P.K. Verhaar, J.A.N. Hoogduijn, M.J. Osch, G.J.V.M. van |
2012-12-01
|
|
Mesenchymal stem cells derived from adipose tissue are not affected by renal disease
(Article)
Rhijn, M.R.V. van Reinders, M.E. Weimar, W. Hoogduijn, M.J. Klein, J.E.M.M. de Douben, H. Korevaar, S.S. Mensah, F.K.F. Dor, F.J.M.F. IJzermans, J.N.M. Betjes, M.G.H. Baan, C.C. |
2012-10-01
|
|
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies
(Article)
Hoogduijn, M.J. Roemeling-Van Rhijn, M. Korevaar, S.S. Engela, A.U. Weimar, W. Baan, C.C. |
2011-12-01
|
|
Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model
(Article)
Eggenhofer, E. Renner, P. Soeder, Y. Popp, F. Hoogduijn, M.J. Geissler, E.K. Schlitt, H.J. Dahlke, M.H. |
2011-09-01
|
|
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)
(Article)
Popp, F. Fillenberg, B. Graveen, C.A. Zeman, F. Koller, M. Hoogduijn, M.J. Geissler, E.K. Schlitt, H.J. Dahlke, M.H. Eggenhofer, E. Renner, P. Dillmann, J. Benseler, V. Schnitzbauer, A.A. Hutchinson, J. Deans, R. Ladenheim, D. |
2011-07-28
|
|
The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy
(Article)
Hoogduijn, M.J. Popp, F. |
2010-12-01
|
|
Human adipose tissue-derived mesenchymal stem cells induce explosive T-Cell proliferation
(Article)
Crop, M.J. Baan, C.C. Korevaar, S.S. IJzermans, J.N.M. Weimar, W. Hoogduijn, M.J. |
2010-12-01
|
|
Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)
(Article)
Hoogduijn, M.J. Popp, F. Laan, L.J.W. van der Dor, F.J.M.F. IJzermans, J.N.M. Genever, P.G. Lange, C. Durrbach, A. Houtgraaf, J. Christ, B. Seifert, M. Shagidulin, M. Grohnert, A.U. Donckier, V. Deans, R. Ringden, O. Perico, N. Remuzzi, G. Bartholomew, A. Schlitt, H.J. Weimar, W. Baan, C.C. Dahlke, M.H. Crop, M.J. Rhijn, M. van Rowshani, A.T. Eggenhofer, E. Renner, P. Reinders, M.E. Rabelink, T.J. |
2010-07-27
|
|
Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis
(Article)
Riekstina, U. Cakstina, I. Parfejevs, V. Hoogduijn, M.J. Jankovskis, G. Muiznieks, I. Muceniece, R. Ancans, J. |
2010-01-01
|
